share_log

Astria Therapeutics Reports Q2 2022 Cash, Cash Equivalents $102.5M

Benzinga Real-time News ·  Aug 9, 2022 17:20
Astria Therapeutics Reports Q2 2022 Cash, Cash Equivalents $102.5M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment